Work

Shift from Eradication to Control: An Adaptive Therapy Approach

Year: 2026
Type: preprint
Abstract: This theoretical review explores the paradigm shift in oncology from maximum tolerated dose (MTD) eradication strategies to evolutionary-based adaptive therapy. By leveraging intratumoral competition between drug-sensitive and drug-resistant cell populations, adaptive therapy aims to maintain a stable tumor burden, delay treatment resistance, and improve long-term clinical outcomes.
Language: English
Open Access status: green
OpenAlex ID: W7234966294
Cites:
Cited by:
Related to: 10